111 related articles for article (PubMed ID: 24212807)
1. Targeted therapy for biliary tract cancer.
Furuse J; Okusaka T
Cancers (Basel); 2011 May; 3(2):2243-54. PubMed ID: 24212807
[TBL] [Abstract][Full Text] [Related]
2. New developments in systemic therapy for advanced biliary tract cancer.
Morizane C; Ueno M; Ikeda M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Aug; 48(8):703-711. PubMed ID: 29893894
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for cholangiocarcinoma: An update.
Ramírez-Merino N; Aix SP; Cortés-Funes H
World J Gastrointest Oncol; 2013 Jul; 5(7):171-6. PubMed ID: 23919111
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for Biliary Tract Cancer in 2021.
Sasaki T; Takeda T; Okamoto T; Ozaka M; Sasahira N
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300274
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Weigt J; Malfertheiner P
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):395-7. PubMed ID: 20678012
[TBL] [Abstract][Full Text] [Related]
6. Current progress in perioperative chemotherapy for biliary tract cancer.
Ioka T; Shindo Y; Ueno M; Nagano H
Ann Gastroenterol Surg; 2023 Jul; 7(4):565-571. PubMed ID: 37416744
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment of advanced or recurrent biliary tract cancer.
Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
[TBL] [Abstract][Full Text] [Related]
8. The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Furuse J; Ishii H; Okusaka T
Jpn J Clin Oncol; 2013 Jan; 43(1):2-7. PubMed ID: 23100604
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.
Hoyle M; Crathorne L; Peters J; Jones-Hughes T; Cooper C; Napier M; Tappenden P; Hyde C
Health Technol Assess; 2013 Apr; 17(14):1-237. PubMed ID: 23547747
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma.
Zheng WH; Yu T; Luo YH; Wang Y; Liu YF; Hua XD; Lin J; Ma ZH; Ai FL; Wang TL
World J Gastrointest Oncol; 2019 Jun; 11(6):489-498. PubMed ID: 31236199
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review.
Park JO; Oh DY; Hsu C; Chen JS; Chen LT; Orlando M; Kim JS; Lim HY
Cancer Res Treat; 2015 Jul; 47(3):343-61. PubMed ID: 25989801
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.
Lee J; Hong TH; Lee IS; You YK; Lee MA
Cancer Res Treat; 2015 Apr; 47(2):259-65. PubMed ID: 25648099
[TBL] [Abstract][Full Text] [Related]
14. Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.
Tada M; Nakai Y; Sasaki T; Hamada T; Nagano R; Mohri D; Miyabayashi K; Yamamoto K; Kogure H; Kawakubo K; Ito Y; Yamamoto N; Sasahira N; Hirano K; Ijichi H; Tateishi K; Isayama H; Omata M; Koike K
World J Clin Oncol; 2011 Mar; 2(3):158-63. PubMed ID: 21611090
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for biliary tract cancers.
Faris JE; Zhu AX
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):326-36. PubMed ID: 22318523
[TBL] [Abstract][Full Text] [Related]
16. Continuum of care for advanced biliary tract cancers.
Vienot A; Neuzillet C
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):810-824. PubMed ID: 32586782
[TBL] [Abstract][Full Text] [Related]
17. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial.
Markussen A; Jensen LH; Diness LV; Larsen FO
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698410
[TBL] [Abstract][Full Text] [Related]
19. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer.
Azizi AA; Lamarca A; Valle JW
Chin Clin Oncol; 2019 Aug; 8(4):43. PubMed ID: 31431035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
